Skip to main content
Fig. 6 | BMC Molecular and Cell Biology

Fig. 6

From: BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression

Fig. 6

CircPSD3 facilitates PTC tumor growth via modulating miR-526b in vivo. A RT-qPCR results of circPSD3 and miR-526b expressions in IHH4 cells of the control group, sh-circPSD3 group, and sh-circPSD3 + miR-526b inhibitor group (n = 3/group). B Western blot results of RAP2A protein levels in indicated groups (n = 3/group). Full-length blots are presented in Supplementary Fig. 2. C Representative images of tumors collected from mice in the control group, sh-circPSD3 group, and sh-circPSD3 + miR-526b inhibitor group (n = 5/group). D Tumor volumes were detected every 5th day until the 20th day (n = 5/group). E Tumor weights were measured on the 20th day after injection (n = 5/group). **P < 0.01, ***P < 0.001; ##P < 0.01, ###P < 0.001

Back to article page